NEW YORK, NY--(Marketwired - Mar 19, 2014) - IntelliCell Biosciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells ...

Joint pain took over Jim Cole’s life so much so that he decided to try Enbrel, a drug that he said ended up causing him more pain than relief. He stopped playing golf, his favorite past time, and didn ...

NEW YORK, NY--(Marketwired - Mar 24, 2014) - IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells ...

NEW YORK--(BUSINESS WIRE)--Intellicell Biosciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC); (“Intellicell”) or the (“Company”), Intellicell has licensed its ...

NEW YORK--(BUSINESS WIRE)--IntelliCell BioSciences Inc. (“IntelliCell” or the “Company”) today announced that its previously announced merger with Media Exchange Group, Inc. (“MEG”) (OTCQB: CWLCD) has ...

NEW YORK, June 13, 2013 -- /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (SVFC) announces that it has been notified by the US Patent office that its patent for stem cell extraction ...

NEW YORK, NY--(Marketwired - August 21, 2014) - IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous stromal ...

IntelliCell BioSciences announced its flagship cellular laboratory has been inspected by the Food and Drug Administration. The company produces technologies to address regenerative, curative and ...

NEW YORK, Oct. 9, 2012 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (SVFC) announced today that it has been successful in manufacturing stromal vascular cells from Non-Living adipose ...

Partners will investigate stromal vascular fraction cells, the basis of IntelliCell’s product. IntelliCell BioSciences inked a sponsored research agreement with the Institute for Cell Engineering and ...